Latest Boardroom Shifts News

DroneShield Limited reaffirms strong business fundamentals with record revenues in 2025, while addressing recent media reports and initiating an independent governance review.

Belararox Ltd announces the immediate resignation of founding Managing Director Arvind Misra, with Chairman Neil Warburton stepping in as interim leader during the search for a new executive director.

Black Cat Syndicate announces a leadership transition with James Bruce appointed as Managing Director from April 2026, succeeding founder Gareth Solly who will remain as a Non-Executive Director.

The Star Entertainment Group has secured crucial regulatory approvals to convert a $300 million strategic investment by Bally’s Corporation and Investment Holdings into equity, setting the stage for board changes and a path toward financial recovery.

Reece Limited reported a modest revenue decline and earnings pressure in FY25 amid challenging markets but reinforced its long-term growth strategy with a significant share buyback and board renewal. Early FY26 trading shows sales growth driven by network expansion despite ongoing cost pressures.

Alterity Therapeutics announces significant board changes, including the retirement of founding chairman Geoffrey Kempler and appointment of CEO Dr David Stamler as Managing Director, aligning leadership with its Phase 3 clinical ambitions.

Autosports Group Limited reports record FY25 revenue and profit, while announcing a strategic acquisition of 10 Barry Bourke Motors dealerships in Victoria, signaling robust growth momentum into FY26.

Golden State Mining has completed a $1.5 million placement at 0.8 cents per share, appointed Keith Middleton as Managing Director, and launched a strategic review of its gold projects in Western Australia.

4DS Memory Limited has declared invalid a shareholder notice seeking to remove Executive Chairman David McAuliffe and other directors, rejecting calls for an extraordinary general meeting.

Mastermyne’s FY2025 AGM reveals resilience amid sector headwinds, operational disruptions, and legal proceedings, while positioning for growth with new leadership and contracts.

Monash IVF Group reported solid FY25 revenue and EBITDA growth despite sector softness and clinical incidents, while announcing a leadership transition and dividend pause.

Charter Hall Group reported solid FY25 results with 7.4% growth in operating earnings per security and upgraded its FY26 earnings guidance to 95 cents, reflecting robust equity inflows and tenant demand. The company also highlighted significant sustainability progress and board changes at its 2025 AGM.